Ischemic stroke..
Conditions
Interventions
Intervention 1: All patients will be treated wih the rivaroxaban at the appropriate of dose once daily for a year. Patients will be additionally treated with colchicine at the dose of 0.5 mg twice da
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who are admitted with a diagnosis of ischemic stroke and have AF at the time of hospitalization The considered age group is 18 years or older
Exclusion criteria
Exclusion criteria: Allergies and sensitivities to colchicine Patients who are taking corticosteroids, methotrexate, TNFa-blockers, interleukin1 -1b antagonist Patients with inflammatory disease such as lupus, rheumatoid arthritis, connective tissue disease or chronic infections Patients with sever Renal failure ( GFR 2 above normal Patients with moderate to severe cytopenia (plt < 100000, neutrophil count < 1500) or blood dyscrasia Patients who are contraindicated for rivaroxaban Pregnant or lactating women or women in childbearing age who do not take appropriate contraception
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recurrence of stroke. Timepoint: 3, 6, 9 and 12 months after the beginning of study. Method of measurement: Clinical history and imaging finding. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDavood kashipazha
Ahvaz University of Medical Sciences
Outcome results
None listed